Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

European Stocks Seen Higher; China GDP Growth Weighs

Published 19/10/2020, 07:03
Updated 19/10/2020, 07:04
© Reuters.

By Peter Nurse 

Investing.com - European stock markets are seen opening higher Monday, helped by hope of a Covid-19 vaccine this year and renewed talk of a fresh U.S. stimulus package, although Chinese growth data may weigh.

At 2:05 AM ET (0605 GMT), the DAX futures contract in Germany traded 0.6% higher, CAC 40 futures in France climbed 0.4% and the FTSE 100 futures contract in the U.K. rose 0.5%. 

Earlier Monday, China reported that its gross domestic product grew 4.9% in July-September from a year earlier, slower than the median forecast of 5.2%. 

That said, separate monthly indicators still pointed to an expansion in activity in the world’s second-largest economy, with industrial output climbing 6.9% in September from a year earlier and retail sales rising 3.3% last month from a year.

“The market is a bit upset by the 4.9% YoY growth as the consensus has been 5% or more,” said analysts at ING, in a research note. “But the market should recover these losses when it has time to digest the substance of the GDP report instead of just reacting to the headlines.”

European markets have been lifted by comments from U.S. House Speaker Nancy Pelosi, who said on Sunday she was optimistic legislation on a wide-ranging coronavirus relief package could be pushed through before the election.

A deal will have to be done very quickly though, with Pelosi setting a Tuesday deadline for Congress to pass the measures.

European Central Bank President Christine Lagarde continued the theme, telling a French newspaper that Europe must distribute its 750 billion euro recovery fund for the pandemic-hit economy promptly and should debate creating a permanent fiscal tool for the bloc.

Also boosting sentiment was Friday’s news from drugmaker Pfizer (NYSE:PFE) that it could have a coronavirus vaccine ready in the United States by the end of this year. 

The need for a vaccine is readily apparent, with the global total of Covid-19 cases rapidly approaching 40 million. 

Europe currently accounts for over 17% of the global cases and nearly 22% of the deaths. New cases are growing at over 150,000 a day, with many countries reporting record daily increases in the number of coronavirus infections.

In corporate news, Koninklijke Philips (NYSE:PHG) will be in focus after the Dutch medical-technology group said Monday that third-quarter net profit exceeded expectations, and offered up positive guidance.

Also, French food group Danone (PA:DANO) restored its guidance for the full year, while laying out a reorganization of its structure.

Oil prices edged lower Monday on the back of the Chinese GDP news, which depressed hopes for fuel demand.

U.S. crude futures traded 0.1% lower at $41.08 a barrel, while Brent fell 0.1% to $42.88.

Elsewhere, gold futures rose 0.3% to $1,912.85/oz, while EUR/USD traded 0.1% lower at 1.1711.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.